Eton Pharmaceuticals, Inc. - 8-K Filing

Eton Pharmaceuticals submitted a prior approval supplement to expand KHINDIVI's indication to younger pediatric patients.

SEC EDGAR ·

Tickers: $ETON

Read the full article at SEC EDGAR

More Regulatory news